TSLA
Tesla
-- 355.840 NVDA
NVIDIA
-- 138.850 INTC
Intel
-- 23.600 NBIS
NEBIUS
-- 44.490 PLTR
Palantir
-- 119.160 
Update
$Gain Therapeutics (GANX.US)$ Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease
2 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
2 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
annna : short attack
Trytosaveabit OP annna : True! Plus it’s phase 1 so not sure until market open what kinda interest is really there? GL
let it squeeze Trytosaveabit OP : I'm wondering if shorts went a little premature? grabbed the dip and will see what happens...I'm interested.
Trytosaveabit OP let it squeeze : I’m definitely watching